130 related articles for article (PubMed ID: 12686760)
1. Characteristics of attenuating effects of rebamipide, an anti-ulcer agent, on oxidative burst of human neutrophils.
Shimoyama T; Fukuda S; Liu Q; Fukuda Y; Nakaji S; Sugawara K
J Pharmacol Sci; 2003 Feb; 91(2):153-7. PubMed ID: 12686760
[TBL] [Abstract][Full Text] [Related]
2. Nonopsonic activation of neutrophils by Helicobacter pylori is inhibited by rebamipide.
Danielsson D; Jurstrand M
Dig Dis Sci; 1998 Sep; 43(9 Suppl):167S-173S. PubMed ID: 9753245
[TBL] [Abstract][Full Text] [Related]
3. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants.
Suzuki M; Miura S; Mori M; Kai A; Suzuki H; Fukumura D; Suematsu M; Tsuchiya M
Gut; 1994 Oct; 35(10):1375-8. PubMed ID: 7959190
[TBL] [Abstract][Full Text] [Related]
4. In vitro studies indicating antioxidative properties of rebamipide.
Iinuma S; Naito Y; Yoshikawa T; Takahashi S; Takemura T; Yoshida N; Kondo M
Dig Dis Sci; 1998 Sep; 43(9 Suppl):35S-39S. PubMed ID: 9753224
[TBL] [Abstract][Full Text] [Related]
5. Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophils in rats.
Murakami K; Okajima K; Harada N; Isobe H; Okabe H
Dig Dis Sci; 1998 Sep; 43(9 Suppl):139S-142S. PubMed ID: 9753240
[TBL] [Abstract][Full Text] [Related]
6. Effects of rebamipide on gastric cell damage by Helicobacter pylori-stimulated human neutrophils.
Han BG; Kim HS; Rhee KH; Han HS; Chung MH
Pharmacol Res; 1995 Oct; 32(4):201-7. PubMed ID: 8866835
[TBL] [Abstract][Full Text] [Related]
7. Free radical scavenging activity of the novel anti-ulcer agent rebamipide studied by electron spin resonance.
Yoshikawa T; Naito Y; Tanigawa T; Kondo M
Arzneimittelforschung; 1993 Mar; 43(3):363-6. PubMed ID: 8387788
[TBL] [Abstract][Full Text] [Related]
8. The effect of rebamipide on the expression of proinflammatory mediators and apoptosis in human neutrophils by Helicobacter pylori water-soluble surface proteins.
Kim JS; Kim JM; Jung HC; Song IS
Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():45-54. PubMed ID: 12925140
[TBL] [Abstract][Full Text] [Related]
9. Suppressive effect of rebamipide, an antiulcer agent, against activation of human neutrophils exposed to formyl-methionyl-leucyl-phenylalanine.
Kobayashi T; Zinchuk VS; Garcia del Saz E; Jiang F; Yamasaki Y; Kataoka S; Okada T; Tsunawaki S; Seguchi H
Histol Histopathol; 2000 Oct; 15(4):1067-76. PubMed ID: 11005231
[TBL] [Abstract][Full Text] [Related]
10. Rebamipide attenuates indomethacin-induced gastric mucosal lesion formation by inhibiting activation of leukocytes in rats.
Murakami K; Okajima K; Uchiba M; Harada N; Johno M; Okabe H; Takatsuki K
Dig Dis Sci; 1997 Feb; 42(2):319-25. PubMed ID: 9052513
[TBL] [Abstract][Full Text] [Related]
11. Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats.
Ogino K; Hobara T; Ishiyama H; Yamasaki K; Kobayashi H; Izumi Y; Oka S
Eur J Pharmacol; 1992 Feb; 212(1):9-13. PubMed ID: 1313372
[TBL] [Abstract][Full Text] [Related]
12. Rebamipide protects against activation of neutrophils by Helicobacter pylori.
Yoshida N; Yoshikawa T; Iinuma S; Arai M; Takenaka S; Sakamoto K; Miyajima T; Nakamura Y; Yagi N; Naito Y; Mukai F; Kondo M
Dig Dis Sci; 1996 Jun; 41(6):1139-44. PubMed ID: 8654144
[TBL] [Abstract][Full Text] [Related]
13. Preventive effect of rebamipide on gastric lesions induced by ischemia-reperfusion in the rat.
Kim CD; Hong KW
J Pharmacol Exp Ther; 1995 Oct; 275(1):340-4. PubMed ID: 7562569
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of rebamipide on the neutrophil adherence stimulated by conditioned media from Helicobacter pylori-infected gastric epithelial cells.
Kim CD; Kim HH; Hong KW
J Pharmacol Exp Ther; 1999 Jan; 288(1):133-8. PubMed ID: 9862763
[TBL] [Abstract][Full Text] [Related]
15. Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
Nagano C; Azuma A; Ishiyama H; Sekiguchi K; Imagawa K; Kikuchi M
J Pharmacol Exp Ther; 2001 Apr; 297(1):388-94. PubMed ID: 11259567
[TBL] [Abstract][Full Text] [Related]
16. Complementarity of in vitro and in vivo models for the evaluation of gastro-protective effects of pharmacological substances.
Goineau S; Castagné V
Fundam Clin Pharmacol; 2017 Apr; 31(2):155-164. PubMed ID: 27739140
[TBL] [Abstract][Full Text] [Related]
17. Gastro-protective agent rebamipide induces cyclooxygenease-2 (COX-2) in gastric epithelial cells.
Murata H; Yabe Y; Tsuji S; Tsujii M; Fu HY; Asahi K; Eguchi H; Kawano S; Hayashi N
Dig Dis Sci; 2005 Oct; 50 Suppl 1():S70-5. PubMed ID: 16184424
[TBL] [Abstract][Full Text] [Related]
18. Preventive effect of rebamipide on gastric mucosal cell damage evoked by activation of formyl-methionyl-leucyl-phenylalanine receptors of rabbit neutrophils.
Kim CD; Hong KW
J Pharmacol Exp Ther; 1997 Apr; 281(1):478-83. PubMed ID: 9103534
[TBL] [Abstract][Full Text] [Related]
19. The antioxidant effect of rebamipide on oxygen free radical production by H. pylori-activated human neutrophils: in comparison with N-acetylcysteine, ascorbic acid and glutathione.
Hong WS; Jung HY; Yang SK; Myung SJ; Kim JH; Min YI; Chung MH; Lee HS; Kim HW
Pharmacol Res; 2001 Oct; 44(4):293-7. PubMed ID: 11592863
[TBL] [Abstract][Full Text] [Related]
20. Rebamipide decreases the susceptibility of gastric mucosa to acid-induced injury in rats by inhibiting neutrophil activation.
Harada N; Okajima K; Liu W
Dig Dis Sci; 2005 Oct; 50 Suppl 1():S56-62. PubMed ID: 16184422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
